Nofel Mahmmod

3.1k citations

29 papers · 741 indexed · h-index 14

Genetics top 5%
- Inflammatory Bowel Disease 22
Epidemiology top 10%
- Microscopic Colitis 12
Gastroenterology top 10%
Hepatology
Oncology
Public Health, Environmental and Occupational Health
- Acute Lymphoblastic Leukemia research 4
Economics and Econometrics
- Health Systems, Economic Evaluations, Quality of Life 4
Surgery
- Eosinophilic Esophagitis 3
Immunology
- Biosimilars and Bioanalytical Methods 3
Pulmonary and Respiratory Medicine
- Gastric Cancer Management and Outcomes 3
Infectious Diseases
- Tuberculosis Research and Epidemiology 2

Co-authors: Andrea E. van der Meulen‐de Jong Ad A. van Bodegraven Bas Oldenburg Mariëlle Romberg‐Camps Björn Winkens Tineke Markus Marie J. Pierik Gerard Dijkstra
Cited by: Genetics Epidemiology Gastroenterology
Journals: Journal of Crohn s and Colitis (10 papers)Gastroenterology (5 papers)Clinical Gastroenterology and Hepatology (4 papers)
Partner nations: Netherlands United States Aruba

In The Last Decade

Nofel Mahmmod

29 papers receiving 731 citations

Peers

Countries citing papers authored by Nofel Mahmmod

Since Specialization

Citations

This map shows the geographic impact of Nofel Mahmmod's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nofel Mahmmod with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nofel Mahmmod more than expected).

Fields of papers citing papers by Nofel Mahmmod

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nofel Mahmmod. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nofel Mahmmod. The network helps show where Nofel Mahmmod may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Nofel Mahmmod, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nofel Mahmmod Line = papers co-authored together Nofel Mahmmod links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	P0027 The carbon footprint of remote monitoring of IBD patients – a green opportunity for sustainable outpatient care Journal of Crohn s and Colitis ·Борщевский Валентин Викентьевич,Charlene Anne,Marin J. de Jong,Marco C. Becx,Ad A. van Bodegraven,Gerard Dijkstra,Merel Kimman,Nofel Mahmmod,Jeroen Maljaars,Andrea E. van der Meulen‐de Jong,Zlatan Mujagic,Mariëlle Romberg‐Camps,Marie J. Pierik,Marjolijn Duijvestein	2025	1
2	Methotrexate accumulation in target intestinal mucosa and white blood cells differs from non‐target red blood cells of patients with Crohn's disease Basic & Clinical Pharmacology & Toxicology ·Mary N. Cameli,Janani Sundaresan,Hillman Yunardhi,Gerrit Jansen,Eduard A. Struys,Herma H. Fidder,Bas Oldenburg,Jeferson Henrique dos Reis Lopes,Nofel Mahmmod,Dirk P. van Asseldonk,Svend T. Rietdijk,Loes H.C. Nissen,Nanne K.H. de Boer,Gerd Bouma,Maja Bulatović Ćalasan,Róbert de Jonge,(unknown)	2024	2
3	Therapeutic drug monitoring of methotrexate in patients with Crohn's disease Alimentary Pharmacology & Therapeutics ·Mary N. Cameli,Herma H. Fidder,Bas Oldenburg,Janani Sundaresan,Eduard A. Struys,Nahid S.M. Montazeri,Jeferson Henrique dos Reis Lopes,Nofel Mahmmod,Dirk P. van Asseldonk,Maurice Lutgens,Johan P. Kuyvenhoven,Svend T. Rietdijk,Loes H.C. Nissen,Parweez Koehestanie,Nanne K.H. de Boer,Róbert de Jonge,Gerd Bouma,Maja Bulatović Ćalasan,(unknown)	2023	13
4	Immunomodulator Withdrawal From Anti-TNF Therapy Is Not Associated With Loss of Response in Inflammatory Bowel Disease Clinical Gastroenterology and Hepatology ·Maxine Frodsham,G. CROCCHIONI,Hervé-landry Kinkani Batekele,汤荣生汤荣生,Rafael Ernesto Mármol Merino,Nofel Mahmmod,О. А. Финаева,Bindia Jharap,Herma H. Fidder,Bas Oldenburg	2022	21
5	P414 Obesity is associated with a higher risk of immunogenicity to adalimumab, but not to infliximab in patients with Inflammatory Bowel Disease Journal of Crohn s and Colitis ·Maxine Frodsham,Yu Fai Yung,Hervé-landry Kinkani Batekele,박표원,Rafael Ernesto Mármol Merino,Nofel Mahmmod,О. А. Финаева,Bindia Jharap,Herma H. Fidder,Bas Oldenburg	2021	2
6	Loss of response to anti‐TNFα agents depends on treatment duration in patients with inflammatory bowel disease Alimentary Pharmacology & Therapeutics ·Yu Fai Yung,Maxine Frodsham,Hervé-landry Kinkani Batekele,Doris Tillmann,Sławomir Sadkowski,Laurent Segers,Nofel Mahmmod,Bindia Jharap,Herma H. Fidder,Bas Oldenburg	2021	31
7	Anti-tumor necrosis factor therapy in patients with inflammatory bowel disease; comorbidity, not patient age, is a predictor of severe adverse events International Journal of Colorectal Disease ·純子宮竹,Nws StormReady Frequently Asked Questions Page,Q. Haly,Yandri Hazriyal,Eelco C. Brand,Andrea E. van der Meulen‐de Jong,Bas Oldenburg,Marieke Pierik,Ingrid S. Lobentanz,Nofel Mahmmod,Jeroen Maljaars,Herma H. Fidder,(unknown)	2020	12
8	Cost-effectiveness of Telemedicine-directed Specialized vs Standard Care for Patients With Inflammatory Bowel Diseases in a Randomized Trial Clinical Gastroenterology and Hepatology ·Marin J. de Jong,Annelies Boonen,Andrea E. van der Meulen‐de Jong,Mariëlle Romberg‐Camps,Ad A. van Bodegraven,Nofel Mahmmod,Tineke Markus,Gerard Dijkstra,Björn Winkens,Astrid van Tubergen,Ad Masclee,Daisy Jonkers,Marie J. Pierik	2020	64
9	P326 Reasons for and effectiveness of switching back to originator infliximab after a prior switch to CT-P13 biosimilar Journal of Crohn s and Colitis ·Zheng Le,Yu Fai Yung,Adriaan C.I.T.L. Tan,Maurice Lutgens,Lennard P. L. Gilissen,Nofel Mahmmod,Andrea E. van der Meulen‐de Jong,Gerard Dijkstra,Ad A. van Bodegraven,Bas Oldenburg,Herma H. Fidder	2020	3
10	Risk of impaired nutritional status and flare occurrence in IBD outpatients Digestive and Liver Disease ·Gislania de Meneses Silva,Florina Cojocaru,Marin J. de Jong,Andrea E. van der Meulen‐de Jong,Mariëlle Romberg‐Camps,Marco C. Becx,Jeroen Maljaars,Ad A. van Bodegraven,Nofel Mahmmod,Tineke Markus,Wim Hameeteman,Ad Masclee,Björn Winkens,Daisy Jonkers,Marie J. Pierik	2019	18
11	High Risk of Advanced Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease Clinical Gastroenterology and Hepatology ·Shailja C. Shah,Joren R. ten Hove,Daniel Castañeda,Carolina Palmela,Erik Mooiweer,Jean‐Frédéric Colombel,Noam Harpaz,Thomas Ullman,Ad A. van Bodegraven,Jeroen M. Jansen,Nofel Mahmmod,Andrea E. van der Meulen‐de Jong,Cyriel Y. Ponsioen,C. Janneke van der Woude,Bas Oldenburg,Steven H. Itzkowitz,Joana Torres	2018	73
12	Malignant and Nonmalignant Complications of the Rectal Stump in Patients with Inflammatory Bowel Disease Inflammatory Bowel Diseases ·Joren R. ten Hove,Ruth Felber Ltd,C. D. Chen,Miangela M. Laclé,Antonio Romero de la Llana,Lauranne Derikx,Frank Hoentjen,Nofel Mahmmod,Bekbergenova Nasiba Neitbaevna,Bas Oldenburg	2018	19
13	Telemedicine for management of inflammatory bowel disease (myIBDcoach): a pragmatic, multicentre, randomised controlled trial The Lancet ·Marin J. de Jong,Andrea E. van der Meulen‐de Jong,Mariëlle Romberg‐Camps,Marco C. Becx,Jeroen Maljaars,Mia Cilissen,Ad A. van Bodegraven,Nofel Mahmmod,Tineke Markus,Wim Hameeteman,Gerard Dijkstra,Ad Masclee,Annelies Boonen,Björn Winkens,Astrid van Tubergen,Daisy Jonkers,Marie J. Pierik	2017	245
14	Smoking is Associated with Higher Disease-related Costs and Lower Health-related Quality of Life in Inflammatory Bowel Disease Journal of Crohn s and Colitis ·Mirjam Severs,Marie‐Josée J. Mangen,Mirthe E. van der Valk,Herma H. Fidder,Gerard Dijkstra,Mike van der Have,Ad A. van Bodegraven,Dirk J. de Jong,C. Janneke van der Woude,Mariëlle Romberg‐Camps,Cees H. Clemens,Jeroen M. Jansen,Paul C. van de Meeberg,Nofel Mahmmod,Cyriel Y. Ponsioen,J Vermeijden,Andrea E. van der Meulen‐de Jong,(unknown),Peter D. Siersema,Bas Oldenburg,(unknown)	2016	20
15	Sa1945 Lower Quality of Life, More Active Disease and Increased Healthcare Costs Due to Non-Adherence in Inflammatory Bowel Disease Gastroenterology ·Mirjam Severs,Marie‐Josée J. Mangen,Herma H. Fidder,Mirthe E. van der Valk,Mike van der Have,Adriaan A. van Bodegraven,Cees H. Clemens,Gerard Dijkstra,Alyssa Wick Nick,Dirk J. de Jong,Nofel Mahmmod,Paul C. van de Meeberg,Andrea E. van der Meulen‐de Jong,(unknown),Cyriel Y. Ponsioen,Mariëlle Romberg‐Camps,Peter D. Siersema,赵金浩,C. Janneke van der Woude,Peter Zuithoff,Bas Oldenburg	2016	2
16	Safety of Tioguanine During Pregnancy in Inflammatory Bowel Disease Journal of Crohn s and Colitis ·杨贵仁,Marjon A. de Boer,Andrea E. van der Meulen‐de Jong,Jeroen M. Jansen,Frank Hoentjen,Maurice G. Rüssel,Nofel Mahmmod,Adriaan A. van Bodegraven,C. Janneke van der Woude,Chris J. Mulder,Nanne K.H. de Boer	2015	12
17	Incidence of Interval Colorectal Cancer Among Inflammatory Bowel Disease Patients Undergoing Regular Colonoscopic Surveillance Clinical Gastroenterology and Hepatology ·Erik Mooiweer,Andrea E. van der Meulen‐de Jong,Cyriel Y. Ponsioen,C. Janneke van der Woude,Ad A. van Bodegraven,Jeroen M. Jansen,Nofel Mahmmod,Huang Shuliang,Peter D. Siersema,Bas Oldenburg	2015	65
18	Mo1671 Incidence of Interval Colorectal Cancer Among Inflammatory Bowel Disease Patients Enrolled in a Colonoscopic Surveillance Program Gastroenterology ·Erik Mooiweer,Andrea E. van der Meulen‐de Jong,Cyriel Y. Ponsioen,C. Janneke van der Woude,Jeroen M. Jansen,Nofel Mahmmod,Huang Shuliang,Peter D. Siersema,Bas Oldenburg	2014	2
19	Neoplasia Yield and Colonoscopic Workload of Surveillance Regimes for Colorectal Cancer in Colitis Patients Inflammatory Bowel Diseases ·Erik Mooiweer,Andrea E. van der Meulen‐de Jong,Adriaan A. van Bodegraven,Jeroen M. Jansen,Nofel Mahmmod,鈴木ひろ枝,Martijn G.H. van Oijen,Peter D. Siersema,Bas Oldenburg	2013	14
20	Use of Multilocus Variable-Number Tandem-Repeat Analysis for TypingMycobacterium aviumsubsp.paratuberculosis Journal of Clinical Microbiology ·Pier Paul Overduin,Leo M. Schouls,Paul Roholl,Michael Schmitt,Nofel Mahmmod,Arnold Herrewegh,Dick van Soolingen	2004	62

About Nofel Mahmmod

Nofel Mahmmod is a scholar working on Genetics, Epidemiology, Gastroenterology, Speech and Hearing and Immunology, having authored 29 papers that have together received 741 indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (22 papers), Microscopic Colitis (12 papers), Acute Lymphoblastic Leukemia research (4 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers), Eosinophilic Esophagitis (3 papers), Biosimilars and Bioanalytical Methods (3 papers), Gastric Cancer Management and Outcomes (3 papers) and Tuberculosis Research and Epidemiology (2 papers). The work is most often cited by research in Genetics (438 citations), Epidemiology (342 citations), Gastroenterology (44 citations), Hepatology (46 citations) and Oncology (144 citations). Nofel Mahmmod has collaborated with scholars based in Netherlands, United States and Aruba. Frequent co-authors include Andrea E. van der Meulen‐de Jong, Ad A. van Bodegraven, Bas Oldenburg, Mariëlle Romberg‐Camps, Björn Winkens, Tineke Markus, Marie J. Pierik, Gerard Dijkstra, Marin J. de Jong and Daisy Jonkers. Their work appears in journals such as Journal of Crohn s and Colitis, Gastroenterology, Clinical Gastroenterology and Hepatology, Inflammatory Bowel Diseases and Alimentary Pharmacology & Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact